Mucosis Appoints Dr. Roberto Grimaldi As Chief Medical Officer

28-Apr-2010 - Netherlands

Mucosis B.V. announced that Dr. Roberto Grimaldi, MD was appointed Chief Medical Officer at Mucosis. Dr. Grimaldi is an accomplished executive and consultant to the vaccine industry who brings over 25 years of experience. As an expert on vaccine development he will lead the Mucosis development programs into clinical trials in the near future.

Before joining Mucosis as Chief Medical Officer, Dr. Grimaldi was Executive Vice President at Crucell N.V., responsible for product development and regulatory affairs. He also held responsible positions amongst others in Chiron Vaccines, Pharmacia & Upjohn, Sandoz and Farmitalia Carlo Erba. Dr. Grimaldi holds a degree in medicine and surgery from the University of Pavia (Italy), and is specialized in clinical pharmacology..

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...